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We previously examined provider's understanding of the 2013
American College of Cardiology/American Heart Association (ACC/
AHA) cholesterol management guideline (DOI: http://dx.doi.org/10.
1016/j.jacl.2015.11.002)(Virani et al., 2013) [1], and also assessed
whether a case-based educational intervention could improve pro-
viders' knowledge gaps and attitudes towards the guideline (DOI: 10.
1016/j.atherosclerosis.2015.12.044) (Pokharel, et al., 2016) [2]. Here
we describe the dataset that we used to examine our objectives.
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ore speciﬁc sub-
ject areaLipidology and behaviorype of data Multiple choice questions in a questionnaire developed using a conceptual model
[3]ow data was
acquiredSurvey, paper-basedata format Questions tested for validity
xperimental
factorsPre-tested including one-on-one sessionxperimental
featuresPre-tested in 11 providers followed by one-on-one session between a psycho-
metrician and a provider for each questionata source
locationHouston, Texas, USAata accessibility Data within this articleD
Value of the data
 Our tool (dataset) can be used for data collection by researchers and educators to assess provider's
understanding towards the 2013 ACC/AHA cholesterol guideline
 The tool is designed to assess provider's understanding of the guideline in three domains –
knowledge, attitude and behavior towards the 2013 ACC/AHA cholesterol guideline, and it also
provides information about the current practice and perceived barriers towards implementation of
the 2013 ACC/AHA cholesterol guideline
 The tool can also be used to understand the effectiveness of an educational intervention by
comparing change in responses before and after the educational intervention
 The tool can be used for quality improvement initiatives or as part of a research study within one or
more institutions for providers who are in training or currently practicing.1. Data
The tool (dataset) consisted of a questionnaire containing providers' demographic information
followed by the actual survey questions. There were a total of 23 multiple-choice questions and
2 clinical vignettes [1,2].2. Experimental design, materials and methods
Cabana et al. have described a conceptual model as a framework to identify barriers to imple-
mentation of clinical practice guidelines, [3] which have been used in prior studies related to choles-
terol guidelines [4,5]. We identiﬁed providers' knowledge, attitudes and behaviors as the three domains
related to barriers to implementation of the 2013 ACC/AHA cholesterol management guideline as
described in Cabana's model [3]. The questions related to each domain were developed to identify the
salient features of the 2013 ACC/AHA cholesterol guideline [6] and to distinguish these features from
the preceding guideline (National Cholesterol Education Program – Adult Treatment Panel III [ATP-III]
report) [7,8]. We developed this tool with the help of a psychometrician and pre-tested among phy-
sician-in-training, physician-in-practice and physician assistant providers from internal medicine, car-
diology and endocrinology disciplines. Subsequently, a psychometrician conducted a one-on-one ses-
sion with an internal medicine provider to ensure the ﬁdelity of the questions in the tool. We also
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dents and therefore, their responses would not be affected. Fig. 1 links each question to one of the
3 domains. A ﬁlled questionnaire sample data is presented with this article.
In the knowledge domain, we asked whether providers were familiar with the following - the
2013 ACC/AHA guideline; the 4 groups of patients who could potentially beneﬁt from statin therapy
(those with clinical atherosclerotic cardiovascular disease [ASCVD], low density lipoprotein choles-
terol [LDL-C]Z190 mg/dL, patients with diabetes aged 40–75 years, 10-year ASCVD risk Z7.5%); the
10-year ASCVD risk estimator; outcomes calculated by the 10-year ASCVD risk estimator and the
differences between the 10-year ASCVD risk estimator and the Framingham coronary heart disease
risk estimator recommended by the prior ATP-III guideline; ASCVD risk threshold for initiating dis-
cussion regarding beneﬁt and risk of statin therapy; providers’ awareness that LDL-CZ190 mg/dL
could identify patients with genetic hyperlipidemia, such as familial hypercholesterolemia (FH);
deﬁnition of statin dose intensity; and providers’ knowledge regarding the need to measure lipids
after statin initiation to assess response and adherence to lifestyle and pharmacotherapy.
In the attitude domain, we asked providers' agreement with the following: the 2013 ACC/AHA
guideline; belief that use of the new 10-year ASCVD risk estimator will either under- or overestimate
the true 10-year ASCVD risk in their patients; belief that the provider cannot perform guideline-
recommended care; belief that following the 2013 ACC/AHA guideline will not improve cardiovas-
cular outcomes in his/her patients; and whether providers will continue to use a LDL-C target based
treatment approach.
In the behavior domain, we assessed organizational/practice barriers (type of provider [specialist or
primary care], provider-in-training or provider-in-practice, academic vs. private practice setting,
number of years since completion of formal training), and barriers perceived by providers as secondary
to patient factors (e.g. inability to afford medications and non-adherence to lipid lowering medication)
as potential reasons for their inability to effectively follow the 2013 ACC/AHA cholesterol guideline.
The questionnaire included two clinical vignettes. The ﬁrst case asked providers for a recom-
mended treatment plan for a patient with LDL-C of 210 mg/dL (likely heterozygous FH). In the second
case, providers were asked whether they would measure a lipid panel in a patient with a recent
myocardial infarction who was started on statin therapy to assess treatment response and adherence.
We administered the questionnaire to providers at local educational conferences at their own
institutions or at regional continuing medical educational activities at 21 sites between September
2014 and April 2015. The response rate was 72.1%; 58% were men, 43% were trainee providers, 49%
were in internal medicine and 27% in cardiology specialty, and 54% practiced in academic setting [1].Acknowledgements
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